The pathogenesis of Alzheimer's disease has been associated with a reduction in the neurotransmitter acetylcholine within the brain, attributed to the aberrant functioning of the enzyme acetylcholinesterase (AChE), which catalyzes the breakdown of acetylcholine into inactive metabolites, namely, choline and acetate. Here, ACHE is linked to Alzheimer disease.